Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer–specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.-Reference-Cited by-同舟云学术

Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer–specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.

Published:2013-10 Issue:4 Volume:64 Page:e86-e87
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bhaskaran Krishnan,Rachet Bernard,Evans Stephen,Smeeth Liam

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Grytli HH, Fagerland MW, Fossa SD, Taskén KA. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007

2. Cardwell CR, Suissa S, Murray LJ. Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol 2013;64:e10.

3. A proportional hazards model for the subdistribution of a competing risk;Fine;J Am Stat Assoc,1999

4. Analysing and interpreting competing risk data;Pintilie;Stat Med,2007

5. Tutorial in biostatistics: competing risks and multi-state models;Putter;Stat Med,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors;Molecular Psychiatry;2022-03-18

2. Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients With Advanced Prostate Cancer: A Veterans Administration Cohort Study;Urology;2021-09

3. Cancer- and noncancer-specific cumulative incidence of death after exposure to polychlorinated biphenyls and dioxins: A competing risk analysis among Yusho patients;Environment International;2021-02

4. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform;The Lancet HIV;2021-01

5. Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis;Journal of Internal Medicine;2020-07-13